iShares US Pharmaceuticals ETF
IHE
IHE
95 hedge funds and large institutions have $96.2M invested in iShares US Pharmaceuticals ETF in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
44% less call options, than puts
Call options by funds: $451K | Put options by funds: $800K
58.99% less ownership
Funds ownership: 140.12% → 81.14% (-59%)
Holders
95
Holding in Top 10
–
Calls
$451K
Puts
$800K
Top Buyers
| 1 | +$6.98M | |
| 2 | +$4.6M | |
| 3 | +$1.92M | |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$802K |
| 5 |
Jane Street
New York
|
+$638K |
Top Sellers
| 1 | -$72.1M | |
| 2 | -$3.82M | |
| 3 | -$3.13M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.57M |
| 5 |
SCP
Syntal Capital Partners
Midland,
Texas
|
-$2.48M |